Xencor Inc. (XNCR)
XNCR trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$23.52
-6.07% on the day
Market cap
$1.7B
Small cap
Revenue · 2025
$125.6M
+13.7% on 2024
Net income · 2025
-$91.9M
-73.2% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | XNCR on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2013 |
| SEC CIK | 0001326732 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $125.6M |
| Net income | -$91.9M |
| Operating income | -$177.5M |
| Net margin | -73.2% |
| Operating margin | -141.4% |
| Revenue growth | +13.7% |
| Cash | $54.1M |
| Total assets | $875.5M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 13.9× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3ASR | 2026-02-25 |
| Latest annual report | 10-K | 2026-02-25 |
| Latest quarterly / interim | 10-Q | 2026-08-05 |
| Latest current report | 8-K | 2026-08-05 |
| Latest proxy | DEFA14A | 2026-04-27 |
Source: SEC EDGAR submissions feed, 890 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -2.9% |
| 1 month | -0.8% |
| 3 months | +57.6% |
| Year to date | +53.9% |
| 1 year | +68.8% |
| From 52-week high | -19.6% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| TRVI | Trevi Therapeutics Inc. | $12.29 | -4.95% | $1.8B |
| SRPT | Sarepta Therapeutics Inc. Common Stock (DE) | $16.51 | -5.33% | $1.7B |
| BRVE | Braveheart Bio Inc. | $19.33 | -5.06% | $1.7B |
| BHVN | Biohaven Ltd. Common Shares | $11.42 | -3.30% | $1.7B |
| ZYME | Zymeworks Inc. | $25.07 | -1.03% | $1.8B |
| SEPN | Septerna Inc. | $36.41 | -3.05% | $1.7B |
| MRVI | Maravai LifeSciences Holdings Inc. | $6.53 | -7.51% | $1.7B |
| AGIO | Agios Pharmaceuticals Inc. | $30.21 | -1.98% | $1.8B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier